Techcyte Inc. closed a $21 million funding round to accelerate commercialization of its digital clinical pathology platform. The investors in this round include Zoetis, ARUP Laboratories and investors from previous rounds.

With offices in Orem, Utah and Luxembourg, Techcyte, Inc. was founded in 2013 with a mission to digitize and automate diagnostics. Techcyte’s clinical pathology platform uses AI-based workflows and integration with whole slide scanners and lab information systems to increase the accuracy and efficiency of clinics and labs. Techcyte’s digital pathology platform is revolutionizing human, veterinary and environmental diagnostic testing.
For additional information, visit www.techcyte.com or call 888-878-3249.

Techcyte Closes $21 Million Funding Round

Description

Company Information

Funding Insights

Techcyte Closes $21 Million Funding Round

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information